The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB)

被引:0
|
作者
Palacios, E
Guerra, D
Llaro, K
Chalco, K
Sapag, R
Furin, J
机构
[1] Socios Salud, Lima, Peru
[2] Harvard Univ, Sch Med, Program Infect Dis & Social Change, Boston, MA USA
关键词
nurse; MDR-TB; community-based; tuberculosis;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Setting: A community-based treatment program for multidrug-resistant tuberculosis (MDR-TB) in Lima, Peru. Objectives: To describe the activities carried out by the nurses working with the program. Design: A qualitative study using a variety of ethnographic methods, including participant observation, focus groups, and key informant interviews over a 5-year period. Results: Nurses were responsible for carrying out a wide variety of activities within the program. These included patient-focused activities such as identifying patients, evaluating patients prior to starting and during therapy, and managing emergencies; educational activities for both patients and health professionals managing MDR-TB; and coordination activities, including overseeing health workers and communicating between team members. Conclusion: Nurses play a key role in the community-based management of MDR-TB.
引用
收藏
页码:343 / 346
页数:4
相关论文
共 50 条
  • [1] Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
    Ormerod, LP
    BRITISH MEDICAL BULLETIN, 2005, 73-74 : 17 - 24
  • [2] New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Schaberg, T.
    Otto-Knapp, R.
    Bauer, T.
    PNEUMOLOGIE, 2015, 69 (05): : 282 - 286
  • [3] Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
    Taylor, Holly A.
    Dowdy, David W.
    Searle, Alexandra R.
    Stennett, Andrea L.
    Dukhanin, Vadim
    Zwerling, Alice A.
    Merritt, Maria W.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2
  • [4] Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
    Skrahina, Alena
    Hurevich, Henadz
    Zalutskaya, Aksana
    Sahalchyk, Evgeni
    Astrauko, Andrei
    Hoffner, Sven
    Rusovich, Valiantsin
    Dadu, Andrei
    de Colombani, Pierpaolo
    Dara, Masoud
    Van Gemert, Wayne
    Zignol, Matteo
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [5] Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Hassali, Mohamed Azmi
    Kibuule, Dan
    Godman, Brian
    ANTIBIOTICS-BASEL, 2019, 8 (03):
  • [6] Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
    Field, Stephen K.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 137 - 149
  • [7] Multidrug-resistant tuberculosis (MDR-TB) in a BMT recipient.
    Altclas, JD
    Adrian, LO
    Salgueira, CC
    Brennan, VI
    Di Martino, A
    Ritacco, V
    Palmero, D
    BLOOD, 2003, 102 (11) : 445B - 445B
  • [8] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Satria A. Prabowo
    Matthias I. Gröschel
    Ed D. L. Schmidt
    Alena Skrahina
    Traian Mihaescu
    Serap Hastürk
    Rotislav Mitrofanov
    Edita Pimkina
    Ildikó Visontai
    Bouke de Jong
    John L. Stanford
    Père-Joan Cardona
    Stefan H. E. Kaufmann
    Tjip S. van der Werf
    Medical Microbiology and Immunology, 2013, 202 : 95 - 104
  • [9] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Prabowo, Satria A.
    Groeschel, Matthias I.
    Schmidt, Ed D. L.
    Skrahina, Alena
    Mihaescu, Traian
    Hasturk, Serap
    Mitrofanov, Rotislav
    Pimkina, Edita
    Visontai, Ildik
    de Jong, Bouke
    Stanford, John L.
    Cardona, Pere-Joan
    Kaufmann, Stefan H. E.
    Werf, Tjip S. van der
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2013, 202 (02) : 95 - 104
  • [10] Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Sabur, Natasha F.
    Brar, Mantaj S.
    Wu, Lisa
    Brode, Sarah K.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)